Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,340.00
Bid: 12,100.00
Ask: 12,400.00
Change: 0.00 (0.00%)
Spread: 300.00 (2.479%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,340.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Mexican president thanks Biden for COVID shots to ease shortage

Fri, 19th Mar 2021 14:57

(Adds quotes, details, context)

MEXICO CITY, March 19 (Reuters) - Mexico's president thanked
his U.S. counterpart Joe Biden on Friday for agreeing to provide
2.7 million COVID-19 vaccines to help offset a shortfall in its
inoculation drive.

President Andres Manuel Lopez Obrador told a news briefing
that the United States will send doses of AstraZeneca's
vaccine, which are slightly more than the 2.5 million U.S.
officials had previously indicated.

"We thank President Biden for sending us these vaccines,"
Lopez Obrador said in the eastern state of Veracruz, noting the
deal was reached on good terms for Mexico and that he hoped the
vaccines would be arriving from next week.

Due to delays in promised deliveries, Mexico has scrambled
to obtain enough vaccines for its inoculation plans, leaning
increasingly on Russia and China to secure doses.

Officials announced the deal just as Mexico said it would
restrict travel on its southern border with Guatemala to curb
the spread of COVID-19, dovetailing with efforts to contain a
surge in U.S.-bound illegal immigration from Central America.

Mexican and U.S. officials said the two steps were not a
quid pro quo, but foreign policy experts noted that the
agreements suited both governments.

Lopez Obrador said that in return for the vaccines, Mexico
would give the United States what it had "always" given, namely
"friendship and cooperation across all spheres."

He said that the vaccines would help Mexico reach its goal
of inoculating its population of 126 million, beginning with a
first shot for all people over 60 by the end of April.

Lopez Obrador on Friday also praised U.S. drugmaker Pfizer
for its vaccine deliveries, which had previously been
subject to delays due to supply bottlenecks.
(Reporting by Daina Beth Solomon
Editing by Dave Graham and Alexander Smith)

More News
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.